Omicron-specific COVID vaccines on the horizon, Pfizer chief says
Omicron-specific COVID vaccines on the horizon, Pfizer chief says
June 22, 2022, 9:28 AM EDT
CEO of Pfizer Albert Bourla attends the Viva Technology conference dedicated to innovation and startups, at the Porte de Versailles exhibition center in Paris, France June 17, 2022. REUTERS/Benoit Tessier
WASHINGTON, June 22 (Reuters) – COVID-19 vaccines that specifically target the Omicron and other variants are under development, Pfizer Inc’s (PFE.N) chief executive said on Wednesday, adding that the company will be able to quickly adapt shots as the novel coronavirus mutates.
While the ultimate approval decisions rest with U.S. regulatos, “we are ready for that,” the drugmaker’s CEO Albert Bourla told MSNBC in an interview, noting that the Food and Drug Administration is convening a meeting later this month.
Our Standards: The Thomson Reuters Trust Principles.
Source: Reuters
Reuters
